Penumbra Inc
(NYSE:PEN)
$
209.63
0.89 (0.43%)
Market Cap: 8.14 Bil
Enterprise Value: 8.00 Bil
PE Ratio: 616.56
PB Ratio: 7.01
GF Score: 86/100 
Penumbra Inc at Wells Fargo Virtual Healthcare Conference Transcript
Sep 09, 2020 / 07:20PM GMT
Release Date Price:
$203.52
(+2.71%)
Operator
Note that Wells Fargo Securities events are by invitation only. Members of the press or media are not permitted to join. (Operator Instructions) Also, please be advised that today's conference is being recorded.
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Okay. Well, good afternoon, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with the CEO of Penumbra, Adam Elsesser.
Adam, thanks so much for being here.
Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO
Yes. Thanks for having us.
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
So in terms of format, it's going to be a fireside chat for 30 minutes and we'll start with Adam, the recovery.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers